Neutrolis
Cambridge, United States · Founded 2017 · $23.4M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- neutrolis.com
- Total Funding
- $23.4M
- Last Round
- $23.1M Series ADec 2021
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Clinical-stage biotech developing first-in-class therapies targeting neutrophil extracellular traps for autoimmune and inflammatory diseases.
Summary
Neutrolis is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $23.4M in total across 2 rounds, most recently a $23.1M Series A round in Dec 2021. Investors include Morningside Group and Oceanpine Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2021
Sign up to see all 2 events
Funding: Grant through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neutrolis"><img src="https://indexed.vc/api/badge/company/neutrolis" alt="Neutrolis on Indexed.vc" width="260" height="76" /></a>